
Problem statement
Commercial forecasts often ignore real access dynamics (formulary restrictions, prior auth friction), producing forecasts that miss actual uptake. Build a commercial forecasting tool that factors real access conditions into its projections, giving commercial teams a more realistic uptake forecast.
One-pager
Prototype Name: Bridging Market Access Reality with Commercial Forecasts
What the prototype is about: A realistic forecast considering the nuances of Market Access |
Key problem it addresses: Sales forecasts assume that once a drug is prescribed, the patient gets it. For biotech and specialty therapies, the biggest barrier to revenue is patient access — not demand. |
Key features: The user could select USA or EU5 , have visibility and insights on Prior Auth / Affordability barriers/ Persistence -abandonment US |
Expected business impact: Compare the access-adjusted revenue forecast to a traditional sales forecast across regions and payer segments. The forecast is more realistic and accurate. |